Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 ...
Fielding a team of 15 swimmers at WAC (the Indians’ largest roster in several years) Hays High medaled in nine of the 11 ...
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 ...
Israel's Cabinet approved a plan for a land registration process in the occupied West Bank that critics say amounts to a land ...
General Terms and Conditions ...
To fill the talent gap, CS majors could be taught to design hardware, and the EE curriculum could be adapted or even shortened.
O’Shea, now 35 and the oldest skater to make their Olympic debut since 1948 and the oldest Team USA Olympic pairs skater ...
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (?21.6 PPriova ...
Clinical Trials Arena on MSN
Priovant advances CS drug to phase III after 100% response in phase II
Cutaneous sarcoidosis occurs in between 20% and 35% of systemic sarcoidosis patients and there is no approved therapy.
Declares $0.20 Per Share Dividend and Expands Prompt Newbuilding Program Totaling $226m Highlights (in million USD, except EPS) Q4 2025Q4 202412M 202512M 2024Net Revenues $49.4$41.7$158.1$167.5Net ...
Generac Holdings (NYSE:GNRC) has surged 56.65% year-to-date, with shares climbing 36.35% over the past month and 20.51% in the last week. Incredibly, that means Generac is now outperforming 99% of all ...
What Brown has enjoyed most this season is seeing the Celtics organization at its best — watching unproven players like Jordan Walsh and Hugo Gonzalez tremendously impact winning. In his first two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results